Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-91
Closed -$13K 628
2022
Q1
$13K Sell
91
-320
-78% -$49K ﹤0.01% 502
2021
Q4
$72K Sell
411
-150
-27% -$25K ﹤0.01% 317
2021
Q3
$92.9K Buy
561
+150
+36% +$25.8K ﹤0.01% 432
2021
Q2
$73.9K Sell
411
-18
-4% -$3.29K ﹤0.01% 505
2021
Q1
$82.7K Hold
429
﹤0.01% 445
2020
Q4
$86.6K Sell
429
-92
-18% -$19K 0.01% 411
2020
Q3
$109K Hold
521
0.01% 338
2020
Q2
$114K Hold
521
0.01% 305
2020
Q1
$90.3K Sell
521
-390
-43% -$64.4K 0.01% 313
2019
Q4
$140K Sell
911
-12
-1% -$1.79K 0.01% 291
2019
Q3
$140K Hold
923
0.01% 286
2019
Q2
$141K Sell
923
-50
-5% -$7.64K 0.01% 291
2019
Q1
$156K Hold
973
0.02% 268
2018
Q4
$150K Sell
973
-13
-1% -$2.02K 0.02% 256
2018
Q3
$148K Hold
986
0.02% 287
2018
Q2
$133K Hold
986
0.02% 311
2018
Q1
$131K Sell
986
-162
-14% -$21.8K 0.02% 303
2017
Q4
$171K Hold
1,148
0.02% 268
2017
Q3
$151K Buy
+1,148
New +$154K 0.02% 290

Other funds holding CLX

RBC Europe's CLX Position: Q2 2022 in Review

RBC Europe sold out of Clorox (CLX) in Q2 2022, closing a stake of 91 shares — an estimated $13K sold.

RBC Europe first reported a position in CLX in Q3 2017 and held it in 19 quarters. The position peaked at $171K in Q4 2017. 1,082 funds tracked by Wall St. Rank hold CLX as of Q2 2022.

  • RBC Europe reported no remaining Clorox position as of Q2 2022 after selling out during the quarter.
  • RBC Europe sold 91 Clorox shares in Q2 2022, an estimated $13K.
  • RBC Europe first reported a position in Clorox in Q3 2017 and held it in 19 quarters.
  • RBC Europe's Clorox position peaked at $171K in Q4 2017.
  • 1,082 funds tracked by Wall St. Rank held Clorox as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.